Tumor News and Research

RSS

Discovery of metabolic system could lead to new strategies for cancer treatment

Australian researchers have uncovered a metabolic system which could lead to new strategies for therapeutic cancer treatment.

21 Jan 2020

NAU scientists study zebrafish to find powerful melanoma-fighting drugs

Melanoma is the most lethal type of skin cancer and unusually common in Arizona, where residents are exposed to higher-than-average amounts of ultraviolet radiation. However, Northern Arizona University scientists believe the formula for a combination of melanoma-fighting drugs is within reach.

21 Jan 2020

Certain enzymes implicated in diseases like cancer also destroy each other

Like motley bandits, certain enzymes implicated in cancer and other diseases also annihilate each other. A new study reveals details of their mutual foils in the hopes that these behaviors can be leveraged to fight the enzymes' disease potential.

20 Jan 2020

Novel drug inhibits liver damage, obesity and glucose intolerance in mice fed with high-fat diet

Mice given a new drug targeting a key gene involved in lipid and glucose metabolism could tolerate a high-fat diet regimen (composed of 60% fat from lard) without developing significant liver damage, becoming obese, or disrupting their body's glucose balance.

20 Jan 2020

Magnetized molecules help monitor breast cancer

A study published in the journal Proceedings of the National Academy of Sciences reports on a novel type of scanning which uses magnetized molecules to visualize active areas within a breast tumor specifically. This marks the first successful attempt to demonstrate the role of this type of scanning in the field of breast cancer monitoring.

20 Jan 2020

Enzymes that cannibalize each other and promote cancer

A new study to be published this week in the journal The Proceedings of the National Academy of Sciences in the week of January 20, 2020. shows that certain human enzymes play dual roles in health and disease. Not only do they promote the occurrence of cancer and some other illnesses, they also eliminate one another rather like cannibals. The researchers hope this behaviour can be exploited to prevent these enzymes from causing human disease.

20 Jan 2020

Refining pathological classification of breast cancer using multiplexed imaging

Breast cancer progression can vary significantly between patients. Even within the same tumor, different areas may be composed of different types of cells and characterized by different tumor structures.

20 Jan 2020

New melanoma test may better predict recurrence and improve patient care

Researchers at Brigham and Women's Hospital have developed a new technique that improves on the current method for assessing whether primary melanoma is likely to recur and spread, following surgical removal.

20 Jan 2020

Researchers discover new regions of non-coding DNA that may lead to cancer growth

In an unprecedented pan-cancer analysis of whole genomes, researchers at the Ontario Institute for Cancer Research have discovered new regions of non-coding DNA that, when altered, may lead to cancer growth and progression.

17 Jan 2020

New achievement with 3D-printing could have applications in pharmaceutical industry

University of Seville researchers, in collaboration with the University of Nottingham, have managed to create the first image of nanoparticles of stabilized gold with biodegradable and biocompatible systems that have been obtained with 3D-printng techniques.

17 Jan 2020

Improved microfluidic brain chip can assess the effectiveness of cancer drugs in record time

The Akay Lab biomedical research team at the University of Houston is reporting an improvement on a microfluidic brain cancer chip previously developed in their lab.

17 Jan 2020

Estrogen plays a role in expansion of liver metastases in non-sex-specific cancers

It is known that the tumor microenvironment plays an important role in the progression of cancer. But could estrogen present in this microenvironment facilitate the growth of liver metastases in women affected by colon, pancreatic and lung cancers?

17 Jan 2020

UT Southwestern study identifies new vulnerability in kidney tumors

A UT Southwestern researcher led a team that identified a new vulnerability in kidney tumors, the 10th most common cause of cancer death in men and women.

17 Jan 2020

Scientists discover how B-cells in tumor cells promote a favorable immunotherapy response

The white blood cells are potent fighters that protect the body against foreign invaders, including pathogens and cancer cells. Scientists have found that the presence of B cells, which are powerhouses, in tumor cells, combat the disease from within.

16 Jan 2020

New method for detection of microcystins and nodularin in human urine

Blooms of toxin-producing algae exploded in both fresh and salt water ecosystems in southern Florida during the summer months of 2018, impacting wildlife and humans living in these marine environments.

16 Jan 2020

Study sheds light on the role of B cells in cancer immunotherapy

Cancer patients responded better to immunotherapy and had a better prognosis if their melanoma tumors contained specific clusters of B cells, according to new research from Lund University in Sweden.

16 Jan 2020

OGT launches high-quality NGS panel for research into Chronic Lymphocytic Leukemia

Oxford Gene Technology, A Sysmex Group Company, is excited to announce the launch of its SureSeq CLL + CNV Panel — the company’s latest high-quality, next-generation sequencing offering for research into Chronic Lymphocytic Leukaemia.

From Oxford Gene Technology 16 Jan 2020

B cell count tells how certain cancers will respond to immunotherapy

Some melanomas, sarcomas and renal cell carcinomas, but not all, have been found to respond dramatically to new drugs called immune checkpoint blockers, which exploit the body’s known capability to mount an immune response against the foreign antigen-bearing tumor cells.

15 Jan 2020

Immune system contribution to tumor heterogeneity may influence liver cancer growth

Researchers at Mount Sinai School of Medicine say the immune system might contribute to the tumor heterogeneity seen in liver cancer that can affect the rate of cancer growth.

15 Jan 2020

Number of operations performed in a hospital linked to success of cancer surgery

Tumors of the colon, so-called colorectal carcinomas, are the second to third most frequent tumors in women and men in Germany. The surgical removal of the tumors is a central component of the therapy.

14 Jan 2020

Tumor News and Research

Discovery of metabolic system could lead to new strategies for cancer treatment

NAU scientists study zebrafish to find powerful melanoma-fighting drugs

Certain enzymes implicated in diseases like cancer also destroy each other

Novel drug inhibits liver damage, obesity and glucose intolerance in mice fed with high-fat diet

Magnetized molecules help monitor breast cancer

Enzymes that cannibalize each other and promote cancer

Refining pathological classification of breast cancer using multiplexed imaging

New melanoma test may better predict recurrence and improve patient care

Researchers discover new regions of non-coding DNA that may lead to cancer growth

New achievement with 3D-printing could have applications in pharmaceutical industry

Improved microfluidic brain chip can assess the effectiveness of cancer drugs in record time

Estrogen plays a role in expansion of liver metastases in non-sex-specific cancers

UT Southwestern study identifies new vulnerability in kidney tumors

Scientists discover how B-cells in tumor cells promote a favorable immunotherapy response

New method for detection of microcystins and nodularin in human urine

Study sheds light on the role of B cells in cancer immunotherapy

OGT launches high-quality NGS panel for research into Chronic Lymphocytic Leukemia

B cell count tells how certain cancers will respond to immunotherapy

Immune system contribution to tumor heterogeneity may influence liver cancer growth

Number of operations performed in a hospital linked to success of cancer surgery

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News